BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28412586)

  • 1. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.
    Haj Mohammad N; Bernards N; van Putten M; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
    Eur J Cancer; 2017 Jun; 78():28-36. PubMed ID: 28412586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study.
    Dijksterhuis WPM; Verhoeven RHA; Pape M; Slingerland M; Haj Mohammad N; de Vos-Geelen J; Beerepoot LV; van Voorthuizen T; Creemers GJ; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
    Eur J Cancer; 2020 Nov; 139():107-118. PubMed ID: 32980749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands.
    Haj Mohammad N; Bernards N; Besselink MG; Busch OR; Wilmink JW; Creemers GJ; De Hingh IH; Lemmens VE; van Laarhoven HW
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1353-60. PubMed ID: 26995276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
    Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.
    Koppert LB; Lemmens VE; Coebergh JW; Steyerberg EW; Wijnhoven BP; Tilanus HW; Janssen-Heijnen ML
    Br J Surg; 2012 Dec; 99(12):1693-700. PubMed ID: 23132417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative stenting for oesophagogastric cancer: tumour and host factors and prognosis.
    Park JH; Woodley N; McMillan DC; Glen P
    BMJ Support Palliat Care; 2019 Sep; 9(3):332-339. PubMed ID: 29574423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.
    Markar SR; Mackenzie H; Wiggins T; Askari A; Karthikesalingam A; Faiz O; Griffin SM; Birkmeyer JD; Hanna GB
    Br J Surg; 2018 Jan; 105(1):113-120. PubMed ID: 29155448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study.
    Dijksterhuis WPM; Verhoeven RHA; Slingerland M; Haj Mohammad N; de Vos-Geelen J; Beerepoot LV; van Voorthuizen T; Creemers GJ; van Oijen MGH; van Laarhoven HWM
    Int J Cancer; 2020 Apr; 146(7):1889-1901. PubMed ID: 31340065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.
    Nelen SD; van Putten M; Lemmens VEPP; Bosscha K; de Wilt JHW; Verhoeven RHA
    Br J Surg; 2017 Dec; 104(13):1837-1846. PubMed ID: 28791679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival, mortality and morbidity outcomes after oesophagogastric cancer surgery in New South Wales, 2001-2008.
    Smith RC; Creighton N; Lord RV; Merrett ND; Keogh GW; Liauw WS; Currow DC
    Med J Aust; 2014 Apr; 200(7):408-13. PubMed ID: 24794674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.
    Trip AK; Stiekema J; Visser O; Dikken JL; Cats A; Boot H; van Sandick JW; Jansen EP; Verheij M
    Acta Oncol; 2015 Nov; 54(10):1754-62. PubMed ID: 25797568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative gastrectomy for metastatic gastric adenocarcinoma: A national population-based cohort study.
    Kamarajah SK; Markar SR; Phillips AW; Salti GI; Dahdaleh F; Griffiths EA
    Surgery; 2021 Dec; 170(6):1702-1710. PubMed ID: 34389165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008.
    Coupland VH; Lagergren J; Lüchtenborg M; Jack RH; Allum W; Holmberg L; Hanna GB; Pearce N; Møller H
    Gut; 2013 Jul; 62(7):961-6. PubMed ID: 23086798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Gastrectomy and Survival in Patients With Metastatic Gastric Cancer: A Propensity Score-Matched Analysis of a Large Population-Based Study.
    Li Q; Zou J; Jia M; Li P; Zhang R; Han J; Huang K; Qiao Y; Xu T; Peng R; Song Q; Fu Z
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31116140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
    van Putten M; Nelen SD; Lemmens VEPP; Stoot JHMB; Hartgrink HH; Gisbertz SS; Spillenaar Bilgen EJ; Heisterkamp J; Verhoeven RHA; Nieuwenhuijzen GAP
    Br J Surg; 2018 Dec; 105(13):1807-1815. PubMed ID: 30132789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
    Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
    Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands.
    Bernards N; Haj Mohammad N; Creemers GJ; de Hingh IH; van Laarhoven HW; Lemmens VE
    Acta Oncol; 2015 Mar; 54(3):403-10. PubMed ID: 25263080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009.
    Dikken JL; Dassen AE; Lemmens VE; Putter H; Krijnen P; van der Geest L; Bosscha K; Verheij M; van de Velde CJ; Wouters MW
    Eur J Cancer; 2012 May; 48(7):1004-13. PubMed ID: 22456179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery.
    Dikken JL; Wouters MW; Lemmens VE; Putter H; van der Geest LG; Verheij M; Cats A; van Sandick JW; van de Velde CJ
    Br J Surg; 2012 Jul; 99(7):954-63. PubMed ID: 22569956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.
    't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH
    Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.